Navigation Links
Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
Date:4/14/2009

COSTA MESA, Calif., April 14 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced it has reached a development and commercial supply agreement with Hospira Inc.'s One 2 One(R) Global Pharmaceutical Services business unit to manufacture clinical-grade Oxycyte(R). Oxycyte is the company's perfluorocarbon (PFC) therapeutic oxygen carrier. Oxycyte will be manufactured at Hospira's Clayton, North Carolina, facility which specializes in emulsion technology.

Hospira will formulate, fill, finish and label Oxycyte to meet clinical good manufacturing practice (GMP) standards required for use of drugs in human patients. The amount of Oxycyte supplied by Hospira will be sufficient to meet any expected demand for the foreseeable future.

"This agreement connects us to a first-tier contract manufacturer and superbly reliable supplier who will provide us with all the Oxycyte we need to grow the company. As I've previously stated, our strategy is to license marketing rights for individual indications, yet always control the supply of our compound and be able to profit from sales of Oxycyte to licensees," said Chris J. Stern, company chairman and CEO.

The companies are not disclosing the financial terms of the supply agreement.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. The company has under development a perfluorocarbon therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs and medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets includin
'/>"/>

SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
2. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
3. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
4. Oxygen Biotherapeutics, Inc. Expands Board of Directors
5. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
6. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
7. Finesse Introduces TruFluor(TM) DO, a Single-Use Optical Dissolved Oxygen Sensor and Transmitter
8. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
9. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
10. CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
11. CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The New York investment bank KTA Capi...has agreed an AU$6.7 mil convertible note private ...private placement was arranged by KTA Capital as N... New York (PRWEB) November ...nk KTA Capital, LLC ("KTA Capital") has ...
(Date:11/24/2009)...RYandBLENHEIM,Ontario,Nov.24/PRNewswire-FirstCall/...theassetsofHylandSeeds,adivisionofThompsonsLimited...therexpandDowAgroSciences,currentseedsbusinessasth... in 2010 andDowAgroSciencesHerbicideTolerantTrai...ectedinthenearfuture. ,, "Thisacquisitionbrings...
(Date:11/24/2009)...UIS,Nov.24/PRNewswire-FirstCall/--Sigma-AldrichCor...OMXconferenceonTuesday,December1stat1:45PMGMTinLon...audiobroadcastovertheInternetavailableat http://i...ickthe"Webcast"icontoaccessthisfile. ,, About...andHighTechnologycompany.Itschemicalandbiochemical...
(Date:11/24/2009)...AVIK,Iceland,November24/PRNewswire-FirstCall/--deC...pprovalofallofits,"firstday"motionsbytheU.S.Bankru...ourt").deCODElastweekfiledavoluntarypetitionfor,re...iththe,BankruptcyCourt. , Theordersissuedbyth...eitsbusinessduringtheChapter11proceedings.Inpartic...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
... Going green is so 2007. This,year scientists in ... new,earth-friendly trend -- Going Blue., This ne...nology in,North Carolina), one of the country,s ne...and markets new products and technologies derived ...e focus of environmental awareness,from land-based...
... 1, 2008 DaVita Inc., a,leading provider of kidne...idney failure and disease, today announced its for...ter, M.D. will retire effective April 1,2008. Dr. ...as since served,as CMO emeritus in the Office of t...rnh/20020729/DAVITALOGO ), "Charlie has provided ...
...1 Chem Rx,Corporation (OTC Bulletin Board: PMQC, ... pharmacy services, announced today that it has po...al results and discuss 2008 outlook,that was origi... Additional,details about the timing of the 2007 f...onference call will be forthcoming shortly., Abou...
Other Biology Technology:When it Comes to Going Green, These N.C. Scientists are Singing the Blues 2DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D. 2Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results 2
(Date:11/25/2009)... the California Institute of Technology (Caltech) ...e behavior in the fruit fly, Drosophila melanogas... the relationship between the neurotransmitter dop... (ADHD), are described in the December issue of th...tains only about 20,000 neurons and has long been ...
(Date:11/25/2009)...ave easy lives. In addition to mammalian immune sy...mies called bacteriophages, viruses that kill half... bacteria and another class of microorganisms call...ts such as deep-sea volcanic vents) manage just fi...n defense system that helps protect them from many...
(Date:11/25/2009)...the Cell Death Research Laboratory in the Universi...ded the prestigious Johnson & Johnson Focused Fund...brain cell damage in Parkinson,s disease. The awar...port of innovation and excellence in science, was ...r this month at an event at the Hyatt Regency Hote...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 1Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 2Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 3Frost 26 Sullivan Identifies Innovative and Cost Effective Technology as Key Competitive Factor in European Medical Device Market 50860 1Frost 26 Sullivan Identifies Innovative and Cost Effective Technology as Key Competitive Factor in European Medical Device Market 50860 2Frost 26 Sullivan Identifies Innovative and Cost Effective Technology as Key Competitive Factor in European Medical Device Market 50860 3Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 1Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 2Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 3Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 4Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 5
... Hughes Medical Institute researchers have develop...ce, causing blood, bone and liver tumors to self d...f the genome" because it triggers the suicide of c...et the stage for the development of different type...e first time that inactivating the p53 gene is nec...
...search at Ohio State University answers an infecti...n are manually washed dishes? , Jaesung Lee and Me...es in cooler-than-recommended water, numbers of ba...in the Food and Drug Administration,s Food Code. T...e and milk—can be safe havens for bacteria when dr...
...burg, Va., March 26, 2007 ?Common bacteria with an...ess show promise as a biosensor to predict public ...ociety national meeting in Chicago March 25-29, re...rginia College of Osteopathic Medicine (VCOM) will...pe and correlations to brain tissue damage. , M...
Other Biology News:Turning a cellular sentinel into a cancer killer 2Turning a cellular sentinel into a cancer killer 3Turning a cellular sentinel into a cancer killer 4Manual dishwashing study digs up dirt on dish cleanliness 2Manual dishwashing study digs up dirt on dish cleanliness 3Bacterial response to oxidation studied as toxin barometer 2Bacterial response to oxidation studied as toxin barometer 3
Human Interferon (IFN) and Receptor, PCR Array for expression profiling from SuperArray Bioscience
Human Regulatory T cell (Foxp3 / CD4 / CD25) Flow Cytometry staining Kit from eBioscience
Rabbit Anti-ICAD Polyclonal Antibody, Unconjugated from BD Biosciences Pharmingen
Sheep Anti-Human Factor XIII Antibody, Horseradish Peroxidase Conjugated from CEDARLANE Laboratories Limited
Biology Products: